Secondary Logo

AAPA Members can view Full text articles for FREE. Not a Member? Join today!

Institutional members access full text with Ovid®

New medications for treatment of chronic hepatitis C

Murfin, Melissa, PA-C, PharmD, BCACP

Journal of the American Academy of PAs: July 2015 - Volume 28 - Issue 7 - p 57–59
doi: 10.1097/01.JAA.0000466592.48713.85
What's New in Infectious Disease
Buy

Treating chronic hepatitis C is crucial to preventing long-term complications such as cirrhosis and liver cancer. New treatments may improve response rates, but the high cost of therapy is a major concern. This article reviews two of these new treatments, sofosbuvir and simeprevir.

Melissa Murfin is an assistant professor in the PA program at Elon (N.C.) University. The author has disclosed no potential conflicts of interest, financial or otherwise.

Mark E. Archambault, DHSc, PA-C, department editor

Copyright © 2015 American Academy of Physician Assistants
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website